Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Tocilizumab, MS, and NMOSD.
Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Rehabilitation in transverse myelitis.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.

Pages